ENTITY
Chugai Pharmaceutical

Chugai Pharmaceutical (4519 JP)

194
Analysis
Health CareJapan
Chugai Pharmaceutical Company Ltd., manufactures and sells pharmaceuticals in the domestic and international markets through its subsidiaries. The Company develops drugs in the fields of cancer, infectious diseases, bone, blood, and circulatory systems. Chugai Pharmaceutical also conducts research studies on drugs with private and public medical research institutions.
more
03 Nov 2017 08:49

Industrial Capsule: Pharmaceuticals in Japan

Industry’s growth facilitated by healthcare spending as Japan’s society agesThe revenue of Japanese pharmaceutical producers continued to grow in...

bullishCSL Ltd
10 Oct 2017 09:55

Not All Players Are Equal in the Plasma Industry

According to Allied Market Research, the IVIG (intravenous IG) market was valued at US$7.86bn and is expected to reach US$12.36bn by 2022. IVIG is...

09 Oct 2017 16:15

Global Pharmaceuticals: Valuations, Assets and Leverage Up - Margins Down

We examined ten years of accounting and valuation data for the pharmaceutical companies around the world with sales of US$100m+ and created...

21 Sep 2017 05:03

Large-Cap Names that Have Gotten a Lot More Volatile Recently....

We screened for large-cap names in Japan that have recently seen a spike in volatility. We calculated Beta over the last 6 months and compared it...

Share
bullishAstellas Pharma
19 Sep 2017 06:17

Astellas (4503) - PROSPER Data Revives Value Story

For a drug that was targeted to hit US$6~8bil in sales, last year’s US$2.3bil revenue figure for Xtandi was decidedly below par. With the start of...

x